20 Florence Street
59 articles with DNAnexus, Inc.
Collaboration integrates DNAnexus’ proven biomedical data analysis platform with Twist’s NGS Methylation Detection and Unique Molecular Identifier Adapter Systems.
3/16/2022The companies that got money this week were the ones investing in ambitious, future-looking technologies, such as RNA genomics, biochips and antibody-drug conjugates.
New Benchmark Report from NIST, Baylor College of Medicine and DNAnexus Helps Provide Accurate Identification of Variants in Challenging Medically Relevant Genes
Researchers from National Institute of Standards and Technology, Baylor College of Medicine and DNAnexus, Inc., together with other members of the Genome in a Bottle consortium, announce the publication of a comprehensive benchmark dataset comprising 273 challenging medically relevant autosomal genes that are associated with the development of diseases such as homocystinuria and spinal muscular atrophy.
DNAnexus Strengthens Leadership Team with Appointment of Dr. Asha S. Collins as General Manager of Biobanks
DNAnexus, Inc. today announced the appointment of Asha S. Collins, PhD, to General Manager, Biobanks.
DNAnexus, Inc. , the leading cloud-based SaaS company serving the global Healthcare and Life Sciences community, today announced the promotion of Fan Fan, Ph.D., to Chief Product Officer.
Supporting the company’s global biomedical data and informatics platform and expansion in clinical diagnostics, pharmaceuticals, and medical centers
FDA Awards DNAnexus with Five-Year, $20 Million Contract to Power precisionFDA Collaborative Omics Environment in the Cloud
DNAnexus’ FedRAMP-authorized cloud-based platform exemplifies FDA strategy for enhancing the regulatory process through data, technology, and stakeholder engagement.
Experienced senior leader brings blend of strategic and operational skills to support company’s continued growth
Former MedImumune executive hired to grow company’s precision health initiatives and drug discovery programs
DNAnexus Introduces Innovative Clinico-Genomic Browser to Allow Diverse Research Teams to Explore Complex Human Data Sets
The Regeneron Genetics Center successfully deployed the cohort browser against a large genomic and phenotypic UK Biobank data set
Financing to support expansion in translational informatics and drive adoption of DNAnexus Apollo™, a powerful new platform to advance drug discovery and improve clinical outcomes
DNAnexus Powers Research and Analysis of Maize Genomes to Fuel Improvements in the World’s Most Important Grain
Consortium leverages DNAnexus cloud-based platform to scale genome assembly and improve quality for the maize population
DNAnexus Inc. announced today it has been granted an Authority to Operate (ATO) under the Federal Risk and Authorization Management Program (FedRAMP) for the management and analysis of biomedical data on its cloud-based platform.
Announcing the Launch of DNAnexus Apollo, a Powerful New Platform for Clinico-Genomic Data, Providing Valuable Insight into Actionable Biomarkers and Targets
DNAnexus today announced DNAnexus Apollo, an enhanced platform for clinico-genomic data science exploration, analysis, and discovery.
DNAnexus, the global leader in biomedical informatics and data management, today announced the winners of the Mosaic Community Challenge: Clinical Strain Detection, which evaluated the accuracy of microbial strain detection in metagenomic samples.
Researchers from CosmosID and the National Center for Scientific Research of France score highest in microbiome community challenge aimed at benchmarking and improving computational methods for microbial analysis
DNAnexus today announced the availability of its Clinical Trial Solution (CTS) which streamlines the use of next-generation sequencing (NGS) data in regulated clinical trials.
DNAnexus Vertebrate Genomes Project Will Create a Digital Genome Ark; DNAnexus to Support Reference Assemblies of All Vertebrate Species
DNAnexus today announced that the Genome10K’s (G10K) Vertebrate Genomes Project (VGP) will utilize the DNAnexus Platform in assembling and analyzing genomes of all vertebrate species, including 8,000 priority endangered species.
The cash will support expansion in translational informatics, clinical trials, and broadened use of biomedical data.
DNAnexus Integrates Google Brain's DeepVariant, a New Deep Learning Technology, onto Its Cloud-Based Platform
DNAnexus announced the availability of the DeepVariant bioinformatics tool on the DNAnexus Platform.